Indapta Therapeutics

Indapta Therapeutics

Biotechnology

A biotechnology company focused on developing a natural killer cell therapy with potent ADCC activity to treat cancer.

About us

Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Seattle & Houston
Type
Privately Held

Locations

Employees at Indapta Therapeutics

Updates

Similar pages

Funding